University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
- Why do some people evade COVID-19 while others get reinfected?
- Rutgers Scientist Who Researches the Sense of Smell Named Rita Allen Foundation Scholar.
- Classic Car Show and Men’s Health Fair Educates Community About Brain Health.
- Asthma Medication Not Working? Try Another.
- Understanding the Structure of HIV Protein May Lead to Novel Treatments.